UNDERSTANDING BIOSIMILARS
Biosimilars are a type of product which have been designed to be a indistinguishable, both in structure and effect from the original biologic medicine. The advantage of biosimilars is the fact that they are more affordable than their biologic counterparts, which may mean that biosimilars are the future of health-care.
On the front lines in the battle to bring affordable, quality medicines to all is Sandoz, the world leader and pioneer in the field of biosimilars. Their portfolio include the first biosimilar approved by the EU, a biosimilar for neutropenia and the first biosimilar for anemia.
Become a
RSH MEMBER
SRH KNOWLEDGE CENTER
Instant and unlimited access to information.
NEWSLETTER
Be the first to find out about the latest publications added to our database.
EVENTS
Participate in the annual events organized by RHS.
GLOBAL CONTACTS
Get in touch with specialists from all over the world.